InfuSystem Holdings Inc
NYSE American:INFU

  • LAST PRICE
    9.3300
  • TODAY'S CHANGE (%)
    0.0900 (0.9740%)
  • Bid / Lots
    9.0500/ 1
  • Ask / Lots
    9.6000/ 1
  • Open / Previous Close
    9.2600 / 9.2400
  • Day Range
    9.2000
    9.5650
  • 52 Week Range
    5.7350
    10.9900
  • Volume
    79,055

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 18, 2024

  • Nov 8, 2024

  • Nov 7, 2024

      Show headlines and story abstract

    • 6:31AM ET on Thursday Nov 07, 2024 by MT Newswires
      Companies Mentioned: INFU
      06:31 AM EST, 11/07/2024 (MT Newswires) -- ...

    • 6:30AM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: INFU
      Retained deficit (58,194) (58,625) ----------- ---------- Total stockholders' equity 55,513 52,302 ----------- ---------- Total liabilities and stockholders' equity $ 105,303 $ 102,915 =========== ========== INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Nine Months Ended September 30, ---------------------- (in thousands) 2024 2023 ------------------------------------------- ------- ------- OPERATING ACTIVITIES Net income $ 1,412 $ 800 Adjustments to reconcile net income to net cash provided by operating activities: Provision for doubtful accounts (141) (122) Depreciation 8,335 8,621 Loss on disposal of and reserve adjustments for medical equipment 678 1,278 Gain on sale of medical equipment (1,863) (1,990) Amortization of intangible assets 743 743 Amortization of deferred debt issuance costs 58 99 Stock-based compensation 3,276 2,799 Deferred income taxes 1,383 325 Changes in assets - (increase)/decrease: Accounts receivable (1,348) (1,035) Inventories (298) (1,270) Other current assets 385 (1,090) Other assets 1,137 (2,304) Changes in liabilities - (decrease)/increase: Accounts payable and other liabilities (1,229) (289) ------- ------- NET CASH PROVIDED BY OPERATING ACTIVITIES 12,528 6,565 ------- ------- INVESTING ACTIVITIES Purchase of medical equipment (12,162) (8,503) Purchase of property and equipment (562) (616) Proceeds from sale of medical equipment, property and equipment 2,754 3,429 ------- ------- NET CASH USED IN INVESTING ACTIVITIES (9,970) (5,690) ------- ------- FINANCING ACTIVITIES Principal payments on long-term debt (40,415) (43,160) Cash proceeds from long-term debt 39,231 42,788 Debt issuance costs -- (229) Common stock repurchased as part of share repurchase program (981) (153) Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans (625) (1,157) Cash proceeds from exercise of options and ESPP 381 1,032 ------- ------- NET CASH USED IN FINANCING ACTIVITIES (2,409) (879) ------- ------- Net change in cash and cash equivalents 149 (4) Cash and cash equivalents, beginning of period 231 165 ------- ------- Cash and cash equivalents, end of period $ 380 $ 161 ======= =======

Peers Headlines